Research Article
The Influence of Menopause and Inflammation on Redox Status and Bone Mineral Density in Patients with Rheumatoid Arthritis
Table 3
Drugs used for chronic diseases treatment in the study population.
| | Chronic therapy | Healthy controls | Rheumatoid patients | | PreM control () | PostM control () | PreM patient () | PostM patient () |
| | ACE inhibitors | Captopril | 4 (28.6) | 14 (41.2) | 3 (27.3) | 11 (35.5) | | Enalapril | | Ramipril | | Perindopril | | Trandolapril | | Cilazapril | | Perindopril+indapamid | | Lisinopril+hydrochlorothiazide | | Ramipril+ hydrochlorothiazide | | Quinapril+hydrochlorothiazide |
| | Beta-blockers | Atenolol | 4 (28.6) | 5 (14.7) | 1 (9.1) | 9 (29.0) | | Metoprolol | | Bisoprolol | | Nebivolol | | Bisoprolol+hydrochlorothiazide |
| | Ca-antagonists | Amlodipine | / | 2 (5.9) | 1 (9.1) | 2 (6.5) | | Felodipine |
| | Diuretics | Indapamide | / | 1 (2.9) | / | / |
| | Statins | Atorvastatin | / | 2 (5.9) | 1 (9.1) | 1 (3.2) | | Rosuvastatin |
| | Phlebotonics | Diosmine | / | 1 (2.9) | 2 (18.2) | / |
| | Thionamide | Propylthiouracil | 1 (7.1) | 1 (2.9) | 1 (9.1) | / |
| | Thyroid hormones | Levothyroxin | / | 2 (5.9) | 2 (18.2) | 4 (12.9) |
| | Proton pump inhibitors | Pantoprazol | 1 (7.1) | 2 (5.9) | 2 (18.2) | 6 (19.4) |
| | Bronchodilator | Aminophyline | / | / | / | 2 (6.5) | | Fenoterol+iprathropium bromide |
| | H1-antagonists | Hydroxizine hydrochloride | / | 2 (5.9) | / | / | | Cinnarizine |
| | Xanthine oxidase inhibitor | Alopurinol | / | 1 (2.9) | / | / |
| | Prostaglandin analogues | Latanoprost | 1 (7.1) | / | / | / |
| | Ergot alkaloids | Dihydroergotamine | / | 1 (2.9) | / | / |
|
|
Data are presented as a number of participants using specific group of drug (%). PreM: premenopausal; PostM: postmenopausal.
|
